BioMed Realty, a life science developer owned by investment giant Blackstone, has arranged for a $765 million refinance of a 1.3 million-square-foot office and flexible property portfolio.
Blackstone’s BioMed readies $765 million CMBS refinancing deal
Developer to tap debt market for offering backed by eight life sciences properties
CoStar News
January 23, 2025 | 7:46 P.M.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Companies
- BioMed Realty
Real Estate
- Blackstone Inc.
Finance and Insurance